BiomX (PHGE) Operating Leases (2020 - 2025)
BiomX (PHGE) posted Operating Leases of $5.3 million for Q3 2025, down 35.07% sequentially from $8.1 million in Q2 2025, and down 38.89% YoY from $8.7 million in Q3 2024.
BiomX (PHGE) Operating Leases (2020 - 2025) Analysis & Trends
BiomX has reported Operating Leases for 6 years, with the latest figure at $5.3 million in Q3 2025.
- Quarterly Operating Leases fell 38.89% year-over-year to $5.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.3 million (down 38.89% YoY) and the FY2024 annual result came in at $8.5 million, up 161.01% from the prior year.
- Operating Leases eased to $5.3 million in Q3 2025 per PHGE's latest filing, from $8.1 million in the prior quarter.
- Over five years, Operating Leases peaked at $8.8 million in Q2 2024 and troughed at $3.2 million in Q3 2023.
- A 5-year average of $5.4 million and a median of $4.6 million in 2021 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases soared 172.13% in 2024, then sank 38.89% in 2025.
- Over 5 years, Operating Leases stood at $4.8 million in 2021, then dropped by 20.66% to $3.8 million in 2022, then declined by 14.72% to $3.2 million in 2023, then soared by 161.01% to $8.5 million in 2024, then slumped by 37.46% to $5.3 million in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $5.3 million, $8.1 million, and $8.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.29 Mn |
| Jun 30, 2025 | 8.14 Mn |
| Mar 31, 2025 | 8.15 Mn |
| Dec 31, 2024 | 8.45 Mn |
| Sep 30, 2024 | 8.65 Mn |
| Jun 30, 2024 | 8.85 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.59 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Jun 30, 2022 | 4.04 Mn |
| Mar 31, 2022 | 4.57 Mn |
| Dec 31, 2021 | 4.79 Mn |
| Sep 30, 2021 | 4.73 Mn |
| Dec 31, 2020 | 5.03 Mn |